Jerry S. Lanchbury, Chief Scientific Officer at MYRIAD GENETICS INC (MYGN), sold 34,192 shares at $34.55 ($1.2M) on 2014-02-18, disclosed to the SEC on 2014-02-20.
Open-market sale of $1.2M MYGN by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.55 | 10,000 | $346K | 29.2% |
| 2 | $34.55 | 24,192 | $836K | 70.8% |
| Total | $34.55 avg | 34,192 | $1.2M | 100% |
| Filing → |
| MYGN | SELL | 2021-08-06 | $2.0M | — | Filing → |
| MYGN | SELL | 2021-08-05 | $4.5M | — | Filing → |
| MYGN | SELL | 2021-07-14 | $4.9M | — | Filing → |